OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

2025-03-31-accounts

Company registration number 03761793 (England and Wales) Charity registration number 1075661 (England and Wales)

BRITISH FERTILITY SOCIETY LIMITED

ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

BRITISH FERTILITY SOCIETY LIMITED

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees A McTavish
Prof A H Balen
Dr V Bolton
Mr N McClure
Dr J Stewart
S Norcross
K L Woodcock
A Lozada Andrade (Appointed 15 September
2024)
Dr M C Davies
Country of incorporation United Kingdom 03761793
(England and Wales)
Charity registration England and Wales 1075661
Registered office Boundary House
Boston Road
London
England
W7 2QE
Independent examiner Blinkhorns
27 Mortimer Street
London
W1T 3BL

BRITISH FERTILITY SOCIETY LIMITED

CONTENTS

Page
Trustees' report 1 - 5
Independent examiner's report 6
Statement of financial activities 7
Balance sheet 8
Notes to the financial statements 9 - 15

BRITISH FERTILITY SOCIETY LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) FOR THE YEAR ENDED 31 MARCH 2025

The trustees present their annual report and financial statements for the year ended 31 March 2025.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Companies Act 2006, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)".

Objectives and activities

The British Fertility Society (BFS) has continued to develop its activities in relation to the promotion of education and knowledge in the field of infertility, in line with the following objectives:

i. The advancement of education

The Society maintained its membership base at over 1000. Around 650 of these are clinicians, 244 nurses and nearly 80 are scientists. The remainder is made up of counsellors, managers, regulators, lawyers, representatives from pharma and retired members. We also have a category for refugee status which accounts for only 2 at this time.

The Joint Annual Meeting with the Society for Reproduction and Fertility (SRF) and the Association of Reproductive & Clinical Scientists (ARCS) took place in Liverpool on 8-11 January 2025, which was an inperson event that attracted more than 700 registrations and 300+ abstracts. This event has continued to strengthen the Society’s relationships with other professional organisations and has increased its accessibility to all within the profession. A survey of membership revealed that this event was the reason they joined BFS.

The annual BFS Study Week, which took place in person in London in September 2024, had modules including: Fertility Preservation, Creating Modern Families, Pelvic Ultrasound, Persons Responsible Effective Fertility Services, Pre-implantation Genetic Testing, Embryo Transfer & Intra-Uterine Insemination, and Male Fertility. There were around 215 registrations.

The shared Annual Study Week with the RCOG took place in April 2024, as an online meeting with 130 delegates in attendance, 40 of whom were from overseas thus further increasing our international profile. Feedback from the meeting was very positive.

The Society is responsible for the publication of Human Fertility , a multidisciplinary journal, which publishes articles ranging from molecular medicine to practical healthcare delivery and psycho-social aspects of reproductive medicine. All members of the British Fertility Society receive the Journal online as part of their subscription; the readership is still increasing both in the UK and internationally. The journal has moved to Open Access in late 2023, which has enable much wider access to the journal worldwide. Downloads have increased significantly and further work has been undertaken to engage nurse members with research activities.

Significant investment and time has been placed in the upgrade of our website and CRM which will enable us to communicate better with our members and the public. The website is reviewed and updated weekly by Webmaster and secretariat team.

The Society also manages several Special Interest Groups (SIGs). These include the following specialty areas: Law Policy & Ethics, Andrology, and Fertility Preservation. These bring together experts and interested professionals in those fields and enable networking and sharing of good practice. In addition, the Society’s Fertility Education Initiative (FEI) SIG has produced materials, including infographics and videos, to increase knowledge and awareness in matters relating to human fertility amongst the public, particularly young people. Grant funding was obtained to assist with this work. The FEI has made efforts to ensure that its content is aligned with PSHE recommendations (Personal, Social, Health, & Economic education in schools in England).

There have been 2 new SIG’s set up : Research and Innovation SIG which had their first public meeting within the Joint Annual Meeting in January 2024 and has set up a BFS prize to be presented at the shared study week at the RCOG. The other ART SIG has been created to share good practice when near misses or incidences have happened in Centres.

BRITISH FERTILITY SOCIETY LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

ii. The advancement of health

The Joint Annual meeting and two Study Weeks are designed to better equip clinicians, nurses, scientists, and ancillary professionals to deal with matters related to fertility and infertility.

Certification of Training modules also ensure that practitioners reach specific standards in delivering the relevant components of care, always incorporating the latest material and practices for the benefit of those seeking care.

The principles of evidence-based practice, as promoted by the National Institute of Health and Care Excellence (NICE), underpin these and our other training modules. There is continuing interaction with the Royal College of Obstetricians and Gynaecologists, the Human Fertilisation and Embryology Authority and the Department of Health, always striving to improve access to and delivery of high-quality clinical care.

The Society also manages a mentorship programme for health professionals (nurses, doctors and scientists) in the early stages of their careers in fertility care.

iii. The advancement of science

The Joint Annual meeting and the two Study weeks provide opportunities for members to present the results of their research orally and in posters and provide an arena for more general discussion of the latest trends and advances in our specialty.

The Society publishes a journal (Human Fertility) encompassing a mix of invited reviews, original articles, and publication of Policy and Practice statements and opinion papers. The journal also provides a forum for the publication of peer-reviewed articles arising out of the activities of other associations including the Association of Reproductive and Clinical Scientist, BICA and the Royal College of Nursing Fertility Nurses group.

Our Policy & Practice committee continues to co-ordinate reviews in a number of key areas in clinical and laboratory practice. Guideline review follows a systematic process and involves the wider membership of the Society. Several position statements and scientific reviews are published each year in Human Fertility.

iv. The advancement of human rights with respect to equality

Perhaps more than in most branches of medicine, fertility care covers both males and females, and equal emphasis is placed on the delivery of their combined and mutually dependent care with due respect to individual autonomy, justice, and equality legislation. Infertility is recognised as a disease by the World Health Organisation (WHO) and promotion of high-quality care of infertile people is part of our obligation as healthcare professionals to reduce disability, distress, stigmatisation, and disease burden in society.

The BFS Study Week delivers modules in Male Fertility and Creating Modern Families. Our equality and diversity policy is displayed on our website and all members are expected to abide by the standards set out in that document.

v. The relief of those in need because of ill-health and disability

Infertility is designated a disease and a disability by the World Health Organisation. The Society strives to offer education to enable the best care to be given by practitioners to those with fertility problems and the consequent disability.

BRITISH FERTILITY SOCIETY LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Achievements and performance

Significant activities and achievements against objectives

Financial review

Going concern

The Directors' principal aim is to ensure that membership income is sufficient to cover the charity's regular expenditure and to utilise any surplus resources towards the principal objects as set out elsewhere in this report. The intention continues to be to consolidate the current level of reserves to advance the aims and objectives of the Charity. This year a comprehensive review of the reserves and saving accounts has seen the reserves increase which provides comfort when external financial support is requested.

The Trustees have reviewed the circumstances of the Charity and consider that adequate resources continue to be available to fund its activities for the foreseeable future.

Reserves policy

BFS Process for Investments and Reserves

Financial sustainability is crucial to ensure the long-term success of the BFS. Comprehensive financial management is important and needs strategic planning to build and manage the funds effectively. The day-to-day management of funds are held in accordance with the Governance document Financial controls .

This document sets out the BFS’s approach to reserves and investment management, including principles, roles, and procedures to ensure financial sustainability in line with charity best practice.

BFS Strategy

The post of Chair of the Executive Committee is held for a three-year period. Every three years there is a strategy meeting held at the beginning of the new Chair’s term to determine and set a three-year plan, at which the Treasurer should be in a position to advise if there is funding available to support proposed activities. Operating reserves are held to meet short-term commitments, while designated reserves fund medium or long-term plans.

BRITISH FERTILITY SOCIETY LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Operating Reserves

The purpose of holding operating reserves is to ensure the BFS has enough cash on hand to cover ongoing operational costs in case of unexpected shortfalls in revenue.

The amount of cash held should be reviewed annually by the Trustees to ensure the BFS can meet all its contractual obligations e.g.

These operating reserves should come from net income or surplus funds and should be reviewed annually as part of the budget-setting process. These funds should be readily available whilst gaining interest in the most favourable possible account.

Designated Reserves

Should the BFS as part of their strategy consider longer term projects then funding should be made secure and ring fenced for the purpose agreed e.g. if a project is agreed to run for a 3-year period at £15,000 per year then £45,000 should be set aside in year one and ring fenced when budgets are set the following two years. This longer-term contract can enable the funds to be placed in accounts that may have higher interest rates.

Financial Services Compensation Scheme (FSCS)

At this time the FSCS will automatically compensate account holders up to £85,000 if held in a UK authorised bank. Therefore, the treasurer should consider moving money out of any account which has a balance greater than the compensation limit covered by the FSCS.

Therefore, the use of a financial company that can provide the same FSCS protection as if the deposit had been placed directly with a bank would provide portfolio management by spreading funds across a variety of investment opportunities to meet the BFS needs whilst keeping the compensation level safe.

This can provide the opportunity to make long-term investments to enable higher interest rates whilst also attracting high rates for a readily accessible account.

Decision makers

The BFS Treasurer, supported by the Chair and Secretary, should explore options regarding which financial institution would best meet the BFS needs and prepare a paper for the Trustees to consider. Most of the companies do not charge an admin or management fee as they take a small cut of their partner banks’ interest rates; however, if this is not the case these costs need to be clarified.

Key Performance Indicators

The Treasurer provides a finance update at each Executive meeting and an annual report for the Charity Commission which will review the interest rate and confirm that funds are secure. There should also be forecasting of potential interest being accrued in accounts to enable decisions to be made as to where money could be drawn from to make sure the Society can meet demands whilst retaining the best financial gain going forward.

Responsibility of the Trustees

Trustees have an obligation to secure the best financial return within the appropriate level of risk to be spend on the charity’s aims. They also have a legal responsibility to take advice, select the right investments, and communicate their decisions.

BRITISH FERTILITY SOCIETY LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Major risks

The directors are aware of the major risks facing the organisation and continue to develop the strengthened risk register. This clearly lays out the necessary lines of communication and measures required to manage any identified weaknesses.

Structure, governance and management

The charity is a company limited by guarantee without share capital.

The Directors of British Fertility Society Ltd. during the year to 31[st] March 2025 were:

A McTavish Prof A H Balen Dr V Bolton Mr N McClure Dr J Stewart S Norcross K L Woodcock A Lozada Andrade (Appointed 15 September 2024) Dr M C Davies

In summary, the charity has had another influential year and continues to expand its activities.

The trustees' report was approved by the Board of Trustees.

A McTavish Trustee

21 January 2026

BRITISH FERTILITY SOCIETY LIMITED

INDEPENDENT EXAMINER'S REPORT

TO THE TRUSTEES OF BRITISH FERTILITY SOCIETY LIMITED

I report to the trustees on my examination of the financial statements of British Fertility Society Limited (the charity) for the year ended 31 March 2025.

Responsibilities and basis of report

As the trustees of the charity (and also its directors for the purposes of company law), you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006.

Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the Companies Act 2006 and are eligible for independent examination, I report in respect of my examination of the charity’s financial statements carried out under section 145 of the Charities Act 2011. In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the Charities Act 2011.

Independent examiner's statement

Since the charity’s gross income exceeded £250,000, the independent examiner must be a member of a body listed in section 145 of the Charities Act 2011. I confirm that I am qualified to undertake the examination because I am a member of ICAEW, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

James Alexander ACA

Blinkhorns

27 Mortimer Street London W1T 3BL 21 January 2026

BRITISH FERTILITY SOCIETY LIMITED

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 MARCH 2025

Unrestricted
Restricted
funds
funds
2025
2025
Notes
£
£
Income from:
Donations and legacies
3
161,888
(2,000)
Charitable activities
4
143,766
-
Investments
5
5,412
-
Total income
311,066
(2,000)
Expenditure on:
Charitable activities
6
167,418
-
Total expenditure
167,418
-
Net income/(expenditure) and
movement in funds
143,648
(2,000)
Reconciliation of funds:
Fund balances at 1 April 2024
345,576
4,324
Fund balances at 31 March
2025
489,224
2,324
Total
Unrestricted
Restricted
funds
funds
2025
2024
2024
£
£
£
159,888
212,766
-
143,766
140,577
-
5,412
1,365
-
309,066
354,708
-
167,418
185,594
-
167,418
185,594
-
141,648
169,114
-
349,900
176,462
4,324
491,548
345,576
4,324
Total
2024
£
212,766
140,577
1,365
354,708
185,594
185,594
169,114
180,786
349,900

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

BRITISH FERTILITY SOCIETY LIMITED

BALANCE SHEET

AS AT 31 MARCH 2025

Notes
Current assets
Debtors
11
Cash at bank and in hand
Creditors: amounts falling due within
one year
12
Net current assets
The funds of the charity
Restricted income funds
14
Unrestricted funds
15
2025
£
87,774
417,402
505,176
(13,628)
£
491,548
2,324
489,224
491,548
2024
£
90,130
337,747
427,877
(77,977)
£
349,900
4,324
345,576
349,900

The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 March 2025.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the trustees on 21 January 2026

A McTavish

Trustee

BRITISH FERTILITY SOCIETY LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

1 Accounting policies

Charity information

British Fertility Society Limited is a private company limited by guarantee incorporated in England and Wales. The registered office is Boundary House, Boston Road, London, W7 2QE, England.

1.1 Basis of preparation

The financial statements have been prepared in accordance with the charity's governing document, the Companies Act 2006, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)". The charity is a Public Benefit Entity as defined by FRS 102.

The charity has taken advantage of the provisions in the SORP for charities not to prepare a statement of cash flows.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

Restricted funds relate to grants that were received in support of the Society's Fertility Education Initiative project, and the expenditure thereon.

1.4 Income

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

The charity received money mainly through membership fees and events occurring throughout the year.

BRITISH FERTILITY SOCIETY LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

1 Accounting policies

(Continued)

1.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset’s use.

1.6 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled.

BRITISH FERTILITY SOCIETY LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

1 Accounting policies

(Continued)

1.8 Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3 Income from donations and legacies

Unrestricted
Restricted
funds
funds
2025
2025
£
£
Donations and gifts
16,762
(2,000)
Membership fees
145,126
-
161,888
(2,000)
Total
Unrestricted
Restricted
funds
funds
2025
2024
2024
£
£
£
14,762
98,099
-
145,126
114,667
-
159,888
212,766
-
Total
2024
£
98,099
114,667
212,766

4 Income from charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Other charitable income
Conferences income 100,929 103,140
Services provided under contract 42,837 37,437
143,766 140,577

BRITISH FERTILITY SOCIETY LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

5 Income from investments

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Interest receivable 5,412 1,365

6 Expenditure on charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Direct costs
Educational expenses 8,990 4,228
Secretarial and other member expenses 153,528 176,626
Accountancy 4,900 4,740
167,418 185,594
Analysis by fund
Unrestricted funds 167,418 185,594
7 Net movement in funds 2025 2024
£ £
The net movement in funds is stated after charging/(crediting):
Fees payable for the independent examination of the charity's financial
statements 4,900 4,740

8 Trustees

The members of the Board of Trustees received no remuneration for their services during the year. Expenses reimbursed to Board of Trustee members for costs incurred on behalf of the charity during the year amounted to £2,371 (2024: £925). This was in respect of 5 Trustees (2024: 3 Trustees).

9 Employees

The average monthly number of employees during the year was:

2025 2024
Number Number
9 8

There were no employees whose annual remuneration was more than £60,000.

BRITISH FERTILITY SOCIETY LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

10 Taxation

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.

11
Debtors
2025
Amounts falling due within one year:
£
Trade debtors
(61)
Prepayments and accrued income
87,835
87,774
12
Creditors: amounts falling due within one year
2025
Notes
£
Deferred income
13
-
Trade creditors
1,807
Other creditors
-
Accruals
11,821
13,628
13
Deferred income
2025
£
Other deferred income
-
Deferred income is included in the financial statements as follows:
2025
£
Deferred income is included within:
Current liabilities
-
Movements in the year:
Deferred income at 1 April 2024
36,477
Released from previous periods
(36,477)
Resources deferred in the year
-
Deferred income at 31 March 2025
-
2024
£
2,409
87,721
90,130
2024
£
36,477
31,299
1,390
8,811
77,977
2024
£
36,477
2024
£
36,477
-
-
36,477
36,477

BRITISH FERTILITY SOCIETY LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

14 Restricted funds

The restricted funds of the charity comprise the unexpended balances of donations and grants held on trust subject to specific conditions by donors as to how they may be used.

At 1 April Incoming At 31 March
2024 resources 2025
£ £ £
4,324 (2,000) 2,324
Previous year: At 1 April Incoming At 31 March
2023 resources 2024
£ £ £
4,324 - 4,324

15 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

At 1 April Incoming Resources At 31 March
2024 resources expended 2025
£ £ £ £
General funds 345,576 311,066 (167,418) 489,224
Previous year: At 1 April Incoming Resources At 31 March
2023 resources expended 2024
£ £ £ £
General funds 176,462 354,708 (185,594) 345,576
Analysis of net assets between funds
Unrestricted Restricted Total
funds funds
2025 2025 2025
£ £ £
At 31 March 2025:
Current assets/(liabilities) 489,224 2,324 491,548
489,224 2,324 491,548

16 Analysis of net assets between funds

BRITISH FERTILITY SOCIETY LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

16 Analysis of net assets between funds (Continued)
Unrestricted Restricted Total
funds funds
2024 2024 2024
£ £ £
At 31 March 2024:
Current assets/(liabilities) 345,576 4,324 349,900
345,576 4,324 349,900

17 Related party transactions

During the year, BFS Education Limited, a company related to British Fertility Society Limited due to their close working, made donations to British Fertility Society Limited totalling £16,762 (2024: £98,099).